Delivery Order SPE2DB20D1100-SPE2DB25FC4D6
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$45K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $11,046.05 and a period of performance through February 11, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting, at a ceiling value of $8,453.38. This is a delivery order contract with a firm fixed-price pricing type. The period of performance extends until August 26, 2024. The contract is not set aside for any specific...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,683.61 firm-fixed-price contract is for the supply of Ondansetron Hydrochloride 8 mg tablets, a medication commonly used to prevent nausea and vomiting. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this delivery order as part of a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,167.61, is for the delivery of ondansetron hydrochloride tablets, a medication used to treat nausea and vomiting. This is a delivery order contract with a firm fixed price, and the ultimate completion date is March 10, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award, valued at $9,701.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron hydrochloride 8 mg tablets, a medication commonly used to prevent nausea and vomiting. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $6,007.11 and an ultimate completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor and is not...
This federal contract award, valued at $18,972.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of 4,566,199,072 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,106,902 units of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price, a ceiling value of $5,957.41, and a performance period through May 2, 2025. The contract is not set-aside and is open to full...